These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28660075)

  • 21. Cross-talk between bile acids and intestinal microbiota in host metabolism and health.
    Nie YF; Hu J; Yan XH
    J Zhejiang Univ Sci B; 2015 Jun; 16(6):436-46. PubMed ID: 26055905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Farnesoid X receptor regulates forkhead Box O3a activation in ethanol-induced autophagy and hepatotoxicity.
    Manley S; Ni HM; Williams JA; Kong B; DiTacchio L; Guo G; Ding WX
    Redox Biol; 2014; 2():991-1002. PubMed ID: 25460735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Editor's Highlight: Farnesoid X Receptor Protects Against Low-Dose Carbon Tetrachloride-Induced Liver Injury Through the Taurocholate-JNK Pathway.
    Takahashi S; Tanaka N; Golla S; Fukami T; Krausz KW; Polunas MA; Weig BC; Masuo Y; Xie C; Jiang C; Gonzalez FJ
    Toxicol Sci; 2017 Aug; 158(2):334-346. PubMed ID: 28505368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression.
    Claudel T; Inoue Y; Barbier O; Duran-Sandoval D; Kosykh V; Fruchart J; Fruchart JC; Gonzalez FJ; Staels B
    Gastroenterology; 2003 Aug; 125(2):544-55. PubMed ID: 12891557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition.
    Vaquero J; Monte MJ; Dominguez M; Muntané J; Marin JJ
    Biochem Pharmacol; 2013 Oct; 86(7):926-39. PubMed ID: 23928191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bile acids regulate intestinal cell proliferation by modulating EGFR and FXR signaling.
    Dossa AY; Escobar O; Golden J; Frey MR; Ford HR; Gayer CP
    Am J Physiol Gastrointest Liver Physiol; 2016 Jan; 310(2):G81-92. PubMed ID: 26608185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COMP is selectively up-regulated in degenerating acinar cells in chronic pancreatitis and in chronic-pancreatitis-like lesions in pancreatic cancer.
    Liao Q; Kleeff J; Xiao Y; Di Cesare PE; Korc M; Zimmermann A; Büchler MW; Friess H
    Scand J Gastroenterol; 2003 Feb; 38(2):207-15. PubMed ID: 12678339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bile acid nuclear receptor FXR and digestive system diseases.
    Ding L; Yang L; Wang Z; Huang W
    Acta Pharm Sin B; 2015 Mar; 5(2):135-44. PubMed ID: 26579439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
    Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
    Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using CRISPR/Cas9 to Knock out Amylase in Acinar Cells Decreases Pancreatitis-Induced Autophagy.
    Yasunaga K; Ito T; Miki M; Ueda K; Fujiyama T; Tachibana Y; Fujimori N; Kawabe K; Ogawa Y
    Biomed Res Int; 2018; 2018():8719397. PubMed ID: 29888283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bile acids and colon cancer: Is FXR the solution of the conundrum?
    Gadaleta RM; Garcia-Irigoyen O; Moschetta A
    Mol Aspects Med; 2017 Aug; 56():66-74. PubMed ID: 28400119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term Administration of Nuclear Bile Acid Receptor FXR Agonist Prevents Spontaneous Hepatocarcinogenesis in Abcb4
    Cariello M; Peres C; Zerlotin R; Porru E; Sabbà C; Roda A; Moschetta A
    Sci Rep; 2017 Sep; 7(1):11203. PubMed ID: 28894223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of farnesoid X receptor and bile acids in alcoholic liver disease.
    Manley S; Ding W
    Acta Pharm Sin B; 2015 Mar; 5(2):158-67. PubMed ID: 26579442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of Farnesoid X Receptor and Bile Acids in Hepatic Tumor Development.
    Takahashi S; Tanaka N; Fukami T; Xie C; Yagai T; Kim D; Velenosi TJ; Yan T; Krausz KW; Levi M; Gonzalez FJ
    Hepatol Commun; 2018 Dec; 2(12):1567-1582. PubMed ID: 30556042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytosol-nucleus traffic and colocalization with FXR of conjugated bile acids in rat hepatocytes.
    Monte MJ; Rosales R; Macias RI; Iannota V; Martinez-Fernandez A; Romero MR; Hofmann AF; Marin JJ
    Am J Physiol Gastrointest Liver Physiol; 2008 Jul; 295(1):G54-G62. PubMed ID: 18467501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of bile acids and bile acid receptors in metabolic regulation.
    Lefebvre P; Cariou B; Lien F; Kuipers F; Staels B
    Physiol Rev; 2009 Jan; 89(1):147-91. PubMed ID: 19126757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RB1CC1-enhanced autophagy facilitates PSCs activation and pancreatic fibrogenesis in chronic pancreatitis.
    Li L; Wang G; Hu JS; Zhang GQ; Chen HZ; Yuan Y; Li YL; Lv XJ; Tian FY; Pan SH; Bai XW; Sun B
    Cell Death Dis; 2018 Sep; 9(10):952. PubMed ID: 30237496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamics of Bile Acid Profiles, GLP-1, and FGF19 After Laparoscopic Gastric Banding.
    Thöni V; Pfister A; Melmer A; Enrich B; Salzmann K; Kaser S; Lamina C; Ebenbichler CF; Hackl H; Tilg H; Moschen AR
    J Clin Endocrinol Metab; 2017 Aug; 102(8):2974-2984. PubMed ID: 28591793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trimethylamine N-Oxide Aggravates Liver Steatosis through Modulation of Bile Acid Metabolism and Inhibition of Farnesoid X Receptor Signaling in Nonalcoholic Fatty Liver Disease.
    Tan X; Liu Y; Long J; Chen S; Liao G; Wu S; Li C; Wang L; Ling W; Zhu H
    Mol Nutr Food Res; 2019 Sep; 63(17):e1900257. PubMed ID: 31095863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Yangonin protects against cholestasis and hepatotoxity via activation of farnesoid X receptor in vivo and in vitro.
    Gao X; Fu T; Wang C; Ning C; Liu K; Liu Z; Sun H; Ma X; Huo X; Yang X; Zou M; Meng Q
    Toxicol Appl Pharmacol; 2018 Jun; 348():105-116. PubMed ID: 29660435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.